Cancer Therapy Expanding to UPMC Altoona for Local Patients

Cancer therapy expanding to UPMC Altoona for local patients

ALTOONA, Pa. (WTAJ) -- Cancer patients in Central Pennsylvania now have greater access to an advanced prostate cancer treatment with the launch of Pluvicto at UPMC Altoona. Beginning in April, UPMC Altoona became the first satellite location within the UPMC Hillman Cancer Center network to offer the specialized radiopharmaceutical therapy for patients with metastatic prostate [...]

Oligometastatic Prostate Cancer — Bridging the Gap between Localized and Metastatic Disease

Results from randomized Phase II trials support the use of metastasis-directed therapy in patients with metachronous oligometastatic prostate cancer. In parallel, prostate-directed treatments such as radiotherapy and cytoreductive radical prostatectomy are under investigation. [Nature Reviews Urology] Abstract